TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Property, Plant and Equipment, Gross USD 2010 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Summary
Teva Pharmaceutical Industries Ltd quarterly Property, Plant and Equipment, Gross history and growth rate from 2010 to 2023.
  • Teva Pharmaceutical Industries Ltd Property, Plant and Equipment, Gross for the quarter ending December 31, 2023 was $11.4 B, a 1.16% increase year-over-year.
Property, Plant and Equipment, Gross, Quarterly (USD)
Property, Plant and Equipment, Gross, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $11.4 B +$130 M +1.16% Dec 31, 2023 10-K 2024-02-12
Q4 2022 $11.3 B +$34 M +0.3% Dec 31, 2022 10-K 2024-02-12
Q4 2021 $11.2 B -$165 M -1.45% Dec 31, 2021 10-K 2023-02-10
Q4 2020 $11.4 B +$38 M +0.34% Dec 31, 2020 10-K 2022-02-09
Q4 2019 $11.4 B -$446 M -3.78% Dec 31, 2019 10-K 2021-02-10
Q3 2019 $11.8 B -$160 M -1.34% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $11.8 B -$131 M -1.1% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $11.8 B -$268 M -2.22% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $11.8 B -$382 M -3.14% Dec 31, 2018 10-K 2020-02-21
Q3 2018 $12 B -$400 M -3.23% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $12 B -$285 M -2.33% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $12.1 B -$51 M -0.42% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 $12.2 B +$252 M +2.11% Dec 31, 2017 10-K 2019-02-19
Q3 2017 $12.4 B +$134 M +1.1% Sep 30, 2017 6-K 2017-11-02
Q2 2017 $12.2 B Jun 30, 2017 6-K 2017-08-03
Q1 2017 $12.1 B Mar 31, 2017 6-K 2017-05-11
Q4 2016 $11.9 B +$1.85 B +18.4% Dec 31, 2016 10-K 2018-02-12
Q3 2016 $12.2 B Sep 30, 2016 6-K 2016-11-15
Q4 2015 $10.1 B +$193 M +1.95% Dec 31, 2015 20-F 2017-02-15
Q4 2014 $9.88 B +$140 M +1.44% Dec 31, 2014 20-F 2016-02-11
Q4 2013 $9.74 B +$602 M +6.59% Dec 31, 2013 20-F 2015-02-09
Q4 2012 $9.14 B +$762 M +9.1% Dec 31, 2012 20-F 2014-02-10
Q4 2011 $8.38 B +$1.76 B +26.5% Dec 31, 2011 20-F 2013-02-12
Q4 2010 $6.62 B Dec 31, 2010 20-F 2012-02-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.